Lessons From The AstraZeneca plc/Pfizer Kerfuffle

In this video, Owain Bennallack looks back at the saga caused by Pfizer‘s initial interest in AstraZeneca (LSE: AZN) (NYSE: AZN.US), and the UK-listed Big Pharma company’s rebuttal of its takeover offers.

Astra's rival GlaxoSmithKline is one of five shares in the FTSE 100 that our top analysts have highlighted in our special report "5 Shares To Retire On". To find out the reasons behind their inclusion, and the names of the other four shares, simply click here to have it delivered completely free to your inbox.

Owain does not own shares in AstraZeneca. The Motley Fool has recommended shares in GlaxoSmithKline.